English
Home > Products > Upadacitinib API

China Upadacitinib API Factory

We have been commitment to offer the aggressive value ,exceptional goods good quality, likewise as fast delivery for Upadacitinib API,CAS NO:2050057-56-0,Upadacitinib hemihydrate API,Upadacitinib hemihydrate,Upadacitinib, For anyone who is fascinated in any of our products and solutions, remember to come to feel totally free to get in touch with us for more facts. We hope to cooperate with additional good friends from everywhere in the world.
Upadacitinib API, We believe in establishing healthy customer relationships and positive interaction for business. Close cooperation with our customers has helped us to create strong supply chains and reap benefits. Our products and solutions have gained us widespread acceptance and the satisfaction of our worldwide valued clients.

Related Products

Hot Products

  • Triethyl orthoformate

    Triethyl orthoformate

    Product Name:Triethyl orthoformate
    Molecular Formula:C7H16O3
    Molecular Weight:148.2
    CAS Registry Number:122-51-0
  • 2-Chloro-5-Iodobnezoic Acid

    2-Chloro-5-Iodobnezoic Acid

    2-Chloro-5-Iodobnezoic Acid
    Molecular Formula: C7H4ClIO2
    Formula Weight: 282.46
    CAS NO:19094-56-5
    Synonyms:5-Iodo-2-chlorobenzoic acid
    Usage:Empagliflozin Intermediates​
  • 4-Hydroxypyridine

    4-Hydroxypyridine

    Product Name:4-Hydroxypyridine
    Molecular Formula:C5H5NO
    Molecular Weight:95.1
    CAS Registry Number:626-64-2
  • Nicorandil

    Nicorandil

    Product Name:Nicorandil
    Molecular Formula:C8H9N3O4
    Molecular Weight;211.17
    CAS Registry Number;65141-46-0
  • Lenvatinib

    Lenvatinib

    Product Name:Lenvatinib
    Molecular Formula:C21H19ClN4O4
    Molecular Weight;426.85
    CAS Registry Number;417716-92-8
  • (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one

    (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one

    Product Name:(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one
    Molecular Formula:C16H12F6N4O2
    Molecular Weight:406.28
    CAS Registry Number:764667-65-4
  • Related Blog
  • Reviews

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • What Is Misoprostol Used For?

    Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept